Results 121 to 130 of about 74,864 (287)

The WHO Classification of Genetic Tumour Syndromes: Considerations for Genetics

open access: yesClinical Genetics, EarlyView.
The WHO Classification of Tumours underpins the diagnosis of neoplastic conditions. The new WHO classification of genetic tumour syndromes (GTS) provides international standards for their diagnosis. This diagram highlights the chromosomal distribution of the genes involved in the GTS covered in this classification.
Ian A. Cree   +18 more
wiley   +1 more source

Papillary Thyroid Cancer

open access: yes, 2021
Jennifer A. Sipos, Bryan R. Haugen
openaire   +2 more sources

The Impact of Change in Practicing Cytopathologists' Team on Risk of Malignancy in a Retrospective Single‐Centre Project of 652 Thyroid Nodules: A Quality Assurance Project

open access: yesCytopathology, EarlyView.
This quality assurance project confirms that thyroid FNAC is a reliable tool for assessing the risk of malignancy (ROM), with ROM rates aligning with published data. However, cytology team changes can reveal interobserver variability and shift category distribution and malignancy rates, underlining the need for ongoing quality assurance and training ...
Pauline Kuerten   +5 more
wiley   +1 more source

EVALUATION OF HISTONE DEACETYLASE INHIBITOR EFFECTS ON THYROID CANCER

open access: yes, 2009
Histone deacetylases (HDACs) play a crucial role in the proper regulation of cellular functions through their connection with chromatin and transcriptional regulation.
Borbone, Eleonora
core  

Five Advances in the Last 50 Years That Have Impacted Endocrine Surgery

open access: yes
World Journal of Surgery, EarlyView.
Matilda Anneback   +5 more
wiley   +1 more source

The Role of SAMHD1 in Viral Resistance and Transduction Efficiency Challenges in Pediatric Hematological Malignancies: Mechanistic Insights and Clinical Perspectives

open access: yesEuropean Journal of Haematology, EarlyView.
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley   +1 more source

Association of FOXE1 polyalanine repeat region with papillary thyroid cancer

open access: yes, 2012
Context: Polyalanine tract variations in transcription factors have been identified for a wide spectrum of developmental disorders. The thyroid transcription factor forkhead factor E1 (FOXE1) contains a polymorphic polyalanine tract with 12-22 alanines ...
Duncan, Emma L.   +11 more
core   +1 more source

Thyroid Ablation: Minimally Invasive to Added Complexity

open access: yes
World Journal of Surgery, EarlyView.
Kelvin Memeh, Priya H. Dedhia
wiley   +1 more source

Validating the 2022 WHO classification in thyroid carcinomas: Prospective evidence for predicting iodine resistance

open access: yesHistopathology, EarlyView.
This study assessed the 2022 WHO classification for predicting RAIR disease in thyroid carcinomas, comparing it to older classifications. In a retrospective study of 253 cases, we found the 2022 classification more effective, especially by identifying high‐grade carcinomas and tumour necrosis as critical predictive factors.
Elise André   +10 more
wiley   +1 more source

Role of Twist1 transcription factor in thyroid tumor progression

open access: yes, 2011
Thyroid carcinomas are the most common endocrine tumors in humans, with a globally increasing incidence. Differentiated tumors, such as papillary (PTC) and follicular (FTC) thyroid cancers, are often curable with surgical resection and radiotherapy ...
Bencivenga, Tammaro Claudio
core  

Home - About - Disclaimer - Privacy